You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 11, November 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  CONTROVERSIES IN NEUROLOGY
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Frontotemporal Degeneration, Pick Disease, and Corticobasal Degeneration

One Entity or 3? 3

David Neary, MD

Arch Neurol. 1997;54(11):1425-1427.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN AD 325, the Council of Nicaea condemned the Arian heresy and proclaimed, in the Athanasian creed, that the Father and Son were not distinct beings, but along with the Holy Spirit were of 1 substance. We are now asked to consider whether frontotemporal lobar degeneration (FTLD), Pick disease, and corticobasal degeneration are 1 or 3 entities. This controversy, in common with theological debate, depends on terminological distinctions, traditionally held beliefs, and a degree of ancestor worship, not to mention proprietary politics.

It was Pick who first described circumscribed frontotemporal atrophy.1-4 His was an anatomical observation, and the histological condition of ballooned cells and inclusion bodies that now bears his name was only later described by Alzheimer.5 Moreover, Pick's cases were clinically heterogeneous. The designation Pick disease, suggesting a unique clinical and pathological entity distinct from Alzheimer disease, gained coinage in the continental literature, but in the English . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Neurology, Manchester Royal Infirmary, Manchester, England.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.